17 results found.

Obsessive-Compulsive Disorder Clinical Trial using N-Acetylcysteine; Placebo

Yale University - Recruiting 8 years to 17 years.
- Double-Blind, Placebo-Controlled Trial of N-acetylcysteine (NAC) for the Treatment of Pediatric Obsessive-Compulsive Disorder.
N-Acetylcysteine; Placebo

Obsessive-Compulsive Disorder Clinical Trial using Deep brain stimulation (DBS)

Butler Hospital - Recruiting 18 years to 75 years.
- Controlled Trial of Deep Brain Stimulation for Obsessive-Compulsive Disorder.
Deep brain stimulation (DBS)

Autism Spectrum Disorder, Obsessive Compulsive Disorder, Pediatri Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Diagnosis and Treatment of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders.

Obsessive-Compulsive Disorder Clinical Trial using Ketamine; Exposure and Response Prevention

New York State Psychiatric Institute - Recruiting 18 years to 55 years.
- Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP).
Ketamine; Exposure and Response Prevention

Patient Diagnosed With OCD, or and Resistant to SSRI Treatment (F Clinical Trial using AFQ056; Placebo

Novartis - Recruiting 18 years to 65 years.
- A Randomized, Double-blind, Placebo-controlled, Parallel-group Proof of Concept Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy.
AFQ056; Placebo

Obsessive-Compulsive Disorder Clinical Trial using Attention Training Program

Humboldt-Universit„t zu Berlin - Recruiting 18 years to 65 years.
- Internet-delivered Attention Training for Obsessive-Compulsive Disorder.
Attention Training Program

Obsessive Compulsive Disorder Clinical Trial using sertraline; psychotherapy

Pfizer - Recruiting 6 years to 16 years.
- Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES).
sertraline; psychotherapy

Obsessive-compulsive Disorder Clinical Trial using Group-based family cognitive-behavioural therapy; Waitlist

University of British Columbia - Recruiting 10 years to 18 years.
- Clinical Outcomes Following Group-based Family Cognitive-Behaviour Therapy in Pediatric Obsessive-Compulsive Disorder (OCD).
Group-based family cognitive-behavioural therapy; Waitlist

Autism Spectrum Disorders, Autism, Asperger's Syndrome, Pervasive Clinical Trial using Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

University of South Florida - Recruiting 8 years to 13 years.
- 2/3 Treatment of Anxiety in Autism Spectrum Disorder.
Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

Obsessive-Compulsive Disorder, Anxiety Disorders, or Mental Disor Clinical Trial using Fluoxetine; Sertraline; Paroxetine; Citalopram; Fluvoxamine; Exposure and Response Prevention

Shanghai Mental Health Center - Recruiting 16 years to 65 years.
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs, and Its Predictors in Obsessive-Compulsive Disorder.
Fluoxetine; Sertraline; Paroxetine; Citalopram; Fluvoxamine; Exposure and Response Prevention

Obsessive Compulsive Disorder Clinical Trial using fluvoxamine maleate; placebo

AbbVie - Recruiting 8 years to 18 years.
- A Phase 3 Study of SME3110 (Fluvoxamine Maleate) in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder.
fluvoxamine maleate; placebo

Obsessive-compulsive Disorder Clinical Trial using Cognitive-behavioral therapy; d-cycloserine; Pill placebo

University of South Florida - Recruiting 7 years to 17 years.
- 1/2 D-cycloserine Augmentation of CBT for Pediatric OCD.
Cognitive-behavioral therapy; d-cycloserine; Pill placebo

Obsessive Compulsive Disorder Clinical Trial using Minocycline; Placebo

New York State Psychiatric Institute - Recruiting 8 years to 20 years.
- A Randomized, Placebo-controlled Trial of Minocycline Added to Serotonin Reuptake Inhibitors in Pediatric OCD: Examining the Effects on Clinical Symptoms and on Brain Glutamate Levels Using MRS Imaging.
Minocycline; Placebo

Obsessive-Compulsive Disorder (OCD) Clinical Trial using Intensive Cognitive Behavioral Therapy (CBT); Waitlist

University of California, Los Angeles - Recruiting 18 years to 65 years.
- Cognitive-Behavioral Therapy and Glutamate in Cingulate Gyrus in OCD.
Intensive Cognitive Behavioral Therapy (CBT); Waitlist

Obsessive Compulsive Disorder Clinical Trial using Topiramate; placebo

McMaster University - Recruiting 18 years to 65 years.
- A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder.
Topiramate; placebo

Obsessive Compulsive Disorder Clinical Trial using Escitalopram

University of Ottawa - Recruiting 13 years to 19 years.
- Treatment With Escitalopram (Cipralexr) for Adolescents With Obsessive-Compulsive Disorder: Efficacy, Safety, and Changes in Executive Functions, Metacognition, and Regional Brain Activations..
Escitalopram